Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: Results of a randomized, controlled study

British Journal of Dermatology

Volumn 155, Issue 3, 2006, Pages 608-613

  Horfelt C ^a   Funk, J ^b   Frohm Nilsson, M ^c   Wiegleb Edstrom D ^c   Wennberg, A M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Dr Funk's Hudklinikk ^*  (Norway)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acne; Methyl aminolaevulinate; Photodynamic therapy; Randomized controlled trial

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; PLACEBO;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHEMA; FACE DISORDER; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN INFLAMMATION; SKIN PAIN; SKIN SWELLING; THERAPY EFFECT;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AMINOLEVULINIC ACID; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33747057121     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07340.x     Document Type: Article

References (26)

1. Webster GF. Acne vulgaris. BMJ 2002; 325:475-9.
2. Charakida A, Seaton ED, Charakida M et al. Phototherapy in the treatment of acne vulgaris. What is its role? Am J Clin Dermatol 2004; 5:211-16.
3. Gollnick H, Cunliffe W, Berson D et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (Suppl. 1): S1-37.
4. Goulden V. Guidelines for the management of acne vulgaris in adolescents. Paediatr Drugs 2003; 5:301-13.
5. Balestrero S, Ciambellotti A, Parodi A, Rebora A. Minocycline-induced lupus-like syndrome. Int J Dermatol 2001; 40:474-5.
6. McLane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol 2001; 45:S188-94.
7. Hull PR, D'Arcy C. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol 2003; 4:493-505.
8. Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology 2003; 206:54-6.
9. Ross JI, Snelling AM, Carnehie E et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148:467-78.
10. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese subjects. Br J Dermatol 2001; 144:575-9.
11. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol 2000; 136:1093-5.
12. Pollock B, Turner D, Stringer MR et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism. Br J Dermatol 2004; 151:616-22.
13. Divaris DX, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathology 1990; 136:891-7.
14. Alster TS, Tanzi EL. Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol 2003; 2:501-4.
15. Hongcharu W, Taylor CR, Chang Y et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115:183-92.
16. Burke BM, Cunliffe WJ. The assessment of acne vulgaris: the Leeds technique. Br J Dermatol 1984; 111:83-92.
17. Elman M, Lebzelter J. Light therapy in the treatment of acne vulgaris. Dermatol Surg 2004; 30:139-46.
18. Rhodes LE, de Rie M, Enström Y et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma. Results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140:17-23.
19. Horn M, Wolf P, Wulf HC et al. Topical methyl aminolevulinate photodynamic therapy in subjects with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149:1242-9.
20. Basset-Seguin N, Ibbotson S, Emtestam L et al. Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Venereol 2001; 15:226.
21. Vinciullo C, Elliott T, Francis D et al. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 2005; 152:765-72.
22. Freeman M, Vinciullo C, Francis D et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003; 14:99-106.
23. Pariser DM, Lowe NJ, Stewart DM et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48:227-32.
24. Peng Q, Moan J, Warloe T et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B: Biol 1996; 34:95-6.
25. Kloek J, Beijersbergen van Henegouwen GMJ. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 1996; 64:994-1000.
26. Fritsch C, Homey B, Stahl W et al. Preferential relative porphyrin enrichment in solar keratoses upon topical application of δ-aminolevulinic acid methylester. Photochem Photobiol 1998; 68:218-21.